SEC Form 4 · accession 0000059478-15-000020
ELI LILLY & Co · LLY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Enrique A Conterno
Officer — Sr. VP & Pres., Lilly Diabetes
Period of report
Jan 28, 2015
Accepted (ET)
Jan 30, 2015 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000059478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 28, 2015 | A | 30,037 | $70.97 | A | 104,400 | D | |
| Common Stock | holding | — | — | — | 4,678 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | — | Jan 28, 2015 | A | 10,360 | A | Feb 1, 2016 | Feb 1, 2016 | Common Stock | 10,360 | 10,360 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.